Dirks JH, Robinson S, Burdmann E, Correa-Rotter R, Mezzano S, Rodriguez-Iturbe B. Prevention strategies for chronic kidney disease in Latin America: a strategy for the next decade - a report on the Villarica Conference. Ren Fail 2006; 28: 611-615....
kidney disease is the eighth leading cause of death and is expected to become the fifth leading cause of death globally by 2040. At present, the incidence rate of kidney disease in China is 10.8%, and the population of chronic kidney disease is more than 100 million. The elderly...
The traditional strategies for prevention and treatment of DKD, i.e., glycemic control and blood pressure management, have only modest effects on minimizing glomerular filtration rate decline or progression to end-stage kidney disease. While cardiovascular outcome trials of SGLT-2i show a positive ...
Premature birth and low birth weight disrupt kidney development substantially, which leads to an increased risk of acute kidney injury, chronic kidney disease and hypertension. Broader awareness of these risks, implementation of preventive strategies and optimization of neonatal care are key to safeguardin...
Therefore, as a complement to clinical approaches to controlling it, a broad and coordinated public health approach will be necessary to meet the burgeoning health, economic, and societal challenges of chronic kidney disease. 展开 关键词: chronic disease prevention public health kidney disease ...
Novel treatment strategies for chronic kidney disease: insights from the animal kingdom Peter Stenvinkel, Johanna Painer, Makoto Kuro-o, Miguel Lanaspa, Walter Arnold, Thomas Ruf, Paul G. Shiels & Richard J. Johnson Nature Reviews Nephrology volume 14, pages 265–284 (2018)Cite ...
Background Costs associated with chronic kidney disease (CKD) are not well documented. Understanding such costs is important to inform economic evaluations of prevention strategies and treatment options. Aim To estimate the costs associated with CKD in Australia. Methods We used data from the 2004/20...
was the seventh leading global level 3 risk factor for death in 2019. The 3 leading global risk factors for kidney disease, including hypertension, diabetes, and overweight/obesity, are also leading global risk factors for death; therefore, holistic strategies are required to address all risk fact...
Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease Curr Opin Nephrol Hypertens, 27 (2018), pp. 420-425 Google Scholar 8 N Jain, RF Reilly Clinical Pharmacology of oral anticoagulants in patients with kidney disease Clin J...
Kidney health for everyone everywhere-from prevention to detection and equitable access to care Kidney Med, 2 (1) (2020), pp. 5-11 View PDFView articleGoogle Scholar 16 K. Kalantar-Zadeh, P.K. Li Strategies to prevent kidney disease and its progression Nat Rev Nephrol, 16 (3) (2020),...